Connect with us


COVID-19 symptoms rarely exceed 12 weeks in young people – Report



LONG COVID symptoms rarely persisted beyond 12 weeks in children and adolescents, unlike adults. But more studies were required to investigate the risk and impact of long COVID in young people to help guide vaccine policy decisions in Australia, according to a review led by the Murdoch Children’s Research Institute (MCRI).

  The review, published in Pediatric Infectious Disease Journal, found that existing studies on long COVID in children and adolescents have major limitations and some do not show a difference in symptoms between those who have been infected by SARS-CoV-2 and those who have not.

  It comes as a new MCRI COVID-19 research brief that also states after 10 months in circulation the Delta strain had not caused more serious disease in children than previous variants and most cases remained asymptomatic or mild.

  However, it found children and adolescents with pre-existing health conditions including obesity, chronic kidney disease, cardiovascular disease, and immune disorders have a 25-fold greater risk of severe COVID-19. A recent systematic review reported severe COVID-19 occurred in 5.1 per cent of children and adolescents with pre-existing conditions and in 0.2 per cent without.

  Murdoch Children’s Research Institute (MCRI)’s Prof. Nigel Curtis, stated that while children with SARS-CoV-2 infection were usually asymptomatic or have mild disease with low rates of hospitalisation, the risk and features of long COVID were poorly understood.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *